Skip to main
OFIX

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical is poised for growth due to its innovative bone growth therapies, spinal implants, biologics, and other cutting-edge technologies. The company's recent strategic realignment of its spine leadership team and strong financials, including a solid Q4 and positive free cash flow for the full year, further demonstrate its potential for success. Despite some challenges, Orthofix's OUTPERFORM investment rating and projected adjusted EBITDA margin show promise for investors in the long-term.

Bears say

Orthofix Medical is a medical device company focused on orthopedics and spine solutions, with the majority of its revenue coming from the global spine segment. The recent fee schedule update for non-invasive bone growth stimulators is expected to have a negative impact on the company's financials and could result in a lower price target, but the company has also taken steps to streamline its operations and affirm its full-year financial guidance. It will be important to closely monitor the company's performance, particularly in the critical U.S. spine and fast-growing U.S. limb reconstruction segments, in the coming quarters. Additionally, while the company has a strong balance sheet and positive free cash flow for the quarter, it will be important to monitor any potential impact on future cash flows due to the fee schedule update.

Orthofix International (OFIX) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Buy based on their latest research and market trends.

According to 4 analysts, Orthofix International (OFIX) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $16, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $16, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.